CNB Bank Has $60,000 Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

CNB Bank lessened its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 23.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,017 shares of the company’s stock after selling 317 shares during the period. CNB Bank’s holdings in DocuSign were worth $60,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DOCU. Nelson Van Denburg & Campbell Wealth Management Group LLC grew its holdings in DocuSign by 440.0% during the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 270 shares of the company’s stock valued at $28,000 after purchasing an additional 220 shares during the last quarter. Capital Analysts LLC grew its stake in shares of DocuSign by 781.7% in the fourth quarter. Capital Analysts LLC now owns 529 shares of the company’s stock worth $31,000 after acquiring an additional 469 shares during the last quarter. BluePath Capital Management LLC acquired a new stake in shares of DocuSign in the third quarter worth $32,000. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of DocuSign in the fourth quarter worth $32,000. Finally, Performa Ltd US LLC grew its stake in shares of DocuSign by 50.0% in the third quarter. Performa Ltd US LLC now owns 825 shares of the company’s stock worth $35,000 after acquiring an additional 275 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Stock Performance

Shares of NASDAQ DOCU traded down $1.34 during midday trading on Friday, reaching $55.70. 2,197,586 shares of the company traded hands, compared to its average volume of 1,551,334. The firm has a market cap of $11.44 billion, a PE ratio of 154.73, a PEG ratio of 4.99 and a beta of 0.89. The stock’s 50-day simple moving average is $55.90 and its 200-day simple moving average is $52.12. DocuSign, Inc. has a 12 month low of $38.11 and a 12 month high of $64.76.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings data on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.09 by $0.06. The company had revenue of $712.39 million during the quarter, compared to analysts’ expectations of $698.05 million. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. On average, equities research analysts expect that DocuSign, Inc. will post 0.86 EPS for the current year.

Insider Buying and Selling at DocuSign

In related news, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Teresa Briggs sold 499 shares of DocuSign stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $52.99, for a total value of $26,442.01. Following the completion of the transaction, the director now directly owns 6,169 shares of the company’s stock, valued at $326,895.31. The disclosure for this sale can be found here. Over the last three months, insiders sold 54,871 shares of company stock valued at $3,176,199. 17.80% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

DOCU has been the topic of several research analyst reports. JMP Securities restated a “market outperform” rating and issued a $84.00 price objective on shares of DocuSign in a research note on Friday, April 12th. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research note on Friday, April 12th. Wells Fargo & Company lowered their price objective on shares of DocuSign from $55.00 to $45.00 and set an “underweight” rating on the stock in a research note on Monday, February 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $59.00 target price on shares of DocuSign in a research report on Friday, April 12th. Finally, Morgan Stanley raised DocuSign from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $49.00 to $64.00 in a research report on Tuesday, January 16th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, DocuSign has a consensus rating of “Hold” and a consensus target price of $60.25.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.